Cullinan Therapeutics presented new preclinical data for CLN-978, a CD19xCD3 bispecific T cell engager, at the American College of Rheumatology

Sobi North America presented data at the ACR Convergence 2025 meeting showcasing the positive impact of their immunology portfolio on

Novartis will present late-breaking data from Phase III trials for ianalumab in Sjögren’s disease and biomarker data for rapcabtagene autoleucel

Kyverna Therapeutics announced positive results from a Phase 1 trial of KYV-101 in patients with difficult-to-treat rheumatoid arthritis. The treatment

Passive investing in ETFs may be losing its appeal, as Tidal Financial Group’s clients seek diversification beyond popular index-linked ETFs

CoreWeave (CRWV) has seen a 207.5% increase in stock price since its IPO in March, indicating strong growth potential. In

XRP may see a 35% breakout to $3.45 by December, supported by bullish technicals and Ripple CEO Brad Garlinghouse’s focus

Over a third of condo apartments in Manhattan sold at a loss in the past year, despite headlines of soaring

Stock market experts warn of a potential significant decline as major indices hit all-time highs. Concerns include rising inflation, ongoing

This week’s earnings calendar features megacap hyperscalers like Meta Platforms (META), Alphabet (GOOGL), Amazon.com (AMZN), Microsoft (MSFT), and Apple (AAPL).

AutoZone reported an $80 million non-cash charge due to tariffs, which is expected to increase to $120 million in the

Intel reported a strong Q3 financial performance, but analysts warn of risks due to struggling manufacturing business. Stock rallied, but

Q3 earnings season started off with negative news from two small regional lenders filing for bankruptcy. JPMorgan Chase CEO Jamie

A man writes seeking advice on his retirement plans after becoming medically disabled. He and his wife plan to move

Tesla’s stock price has defied odds in 2025, rising 13% year to date despite previous challenges. However, issues like declining

Stand, a homeowners insurance provider, closed a $35 million Series B funding round led by Eclipse. The company has already

In the financial publication industry, the idea that fundamental and technical analysis can lead to huge profits is being challenged.

The scariest horrors in life don’t come in costumes – they slash your wallet when you least expect it. Business

BitMine Chairman Tom Lee predicts Bitcoin could soar to $2 million if it matches gold’s market cap, but analysts disagree.

Phathom Pharmaceuticals announced positive results from a Phase 3 trial showing VOQUEZNA provided rapid and sustained relief of nighttime GERD

Bitwise CEO Hunter Horsley noted a trend of more crypto holders revealing themselves, making non-owners feel like the minority. This

Insider buying continues despite market highs. Notable purchases include gold miner stake increase, offshore driller support, and biotech shares acquisition.

Tokenizing real-world assets is not a complete solution to traditional finance issues, facing criticism for complexity, lack of regulation, and

Financial expert Suze Orman discussed the pros and cons of relying on real estate for retirement income on her podcast.